companydata.dkBioTelemetry Technology ApS: Financial statements 2022
CVR: 37552534
BioTelemetry Technology ApS (CVR 37552534) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -115,998 and a net result of DKK -92,258 compared with DKK -126,560 the year before. Equity amounted to DKK 15,090,457. The solvency ratio was 98.2%.
- Gross Profit
- -115,998 kr.
- Profit/Loss
- -92,258 kr.
- Equity
- 15,090,457 kr.
- Total Assets
- 15,373,622 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -116 t. | -92 t. | 15.1 mio. | 0 |
| 2021 | - | -157 t. | -127 t. | 15.2 mio. | - |
| 2020 | - | -124 t. | -1.1 mio. | 15.3 mio. | - |
| 2019 | - | 412 t. | 796 t. | 16.4 mio. | 0 |
| 2018 | - | -1 mio. | -698 t. | 15.7 mio. | 0 |
Keep an eye on BioTelemetry Technology ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BioTelemetry Technology ApS has published its annual report for 2021. Gross profit came to DKK -157,465, and the net result was DKK -126,560.
As of April 11, 2022, Fred Andy Broadway III is registered as director of BioTelemetry Technology ApS.
As of April 11, 2022, Cody William Cowper has stepped down as director of BioTelemetry Technology ApS.
About BioTelemetry Technology ApS
BioTelemetry Technology ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2016 and dissolved in 2023. The company was registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The company has 0 employees. In 2022, the company reported a gross profit of DKK -115,998 and a net result of DKK -92,258 compared with DKK -126,560 the year before. Equity amounted to DKK 15,090,457.